87
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of 4-Methylpyrazole as a Potential Therapeutic Dark Adaptation Inhibitor

, &
Pages 911-915 | Received 23 Jun 2007, Accepted 06 Aug 2007, Published online: 02 Jul 2009

REFERENCES

  • Blacharski P A. Fundus Flavimaculutus. Raven, New York 1988; 135–159
  • Cubeddu R, Taroni P, Hu D N, et al. Photophysical studies of A2-E, putative precursor of lipofuscin, in human retinal pigment epithelial cells. Photochem Photobiol. 1999; 70: 172–175
  • Birnbach C D, Jarvelainen M, Possin D E, et al. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994; 101: 1211–1219
  • Radu R A, Mata N L, Nusinowitz S, et al. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci USA. 2003; 100: 4742–4747
  • Maiti P, Kong J, Kim S R, et al. Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry. 2006; 45: 852–860
  • Radu R A, Han Y, Bui T V, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci. 2005; 46: 4393–4401
  • Lamb T D, Pugh E N, Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res 2004; 23: 307–380
  • Sakmar T P, Menon S T, Marin E P, et al. Rhodopsin: Insights from recent structural studies. Annu Rev Biophys Biomol Struct. 2002; 31: 443–484
  • Parish C A, Hashimoto M, Nakanishi K, et al. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci U.S A. 1998; 95: 14609–14613
  • Sparrow J R, Nakanishi K, Parish C A. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000; 41: 1981–1989
  • Mata N L, Weng J, Travis G H. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A. 2000; 97: 7154–7159
  • Allikmets R. Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet. 2000; 67: 793–799
  • Mycyk M B, Leikin J B. Antidote review: Fomepizole for methanol poisoning. Am J Ther. 2003; 10: 68–70
  • Bernstein P S, Rando R R. In vivo isomerization of all-trans- to 11-cis-retinoids in the eye occurs at the alcohol oxidation state. Biochemistry. 1986; 25: 6473–6478
  • Raskin N H, Sligar K P, Steinberg R H. A pathophysiologic role for alcohol dehydrogenase: is retinol its “natural” substrate?. Ann N Y Acad Sci 1976; 273: 317–327
  • Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem. 2000; 267: 4315–4324
  • Xue L, Gollapalli D R, Maiti P, et al. A palmitoylation switch mechanism in the regulation of the visual cycle. Cell. 2004; 117: 761–771
  • Jacobsen D, Barron S K, Sebastian C S, et al. Non-linear kinetics of 4-methylpyrazole in healthy human subjects. Eur J Clin Pharmacol. 1989; 37: 599–604
  • Blomstrand R, Ingemansson S O, Jensen M. et al. Normal electroretinogram and no toxicity signs after chronic and acute administration of the alcohol dehydrogenase inhibitor 4-methylpyrazole to the cynomolgus monkey (Macaca fascicularis)—a possible new treatment of methanol poisoning. Drug Alcohol Depend 1984; 13: 9–20
  • Blomstrand R, Ingemansson S O. Studies on the effect of 4-methylpyrazole on methanol poisoning using the monkey as an animal model: With particular reference to the ocular toxicity. Drug Alcohol Depend. 1984; 13: 343–355
  • Jobard E, Turcant A, Harry P, et al. High-performance liquid chromatographic determination of 4-methylpyrazole in plasma and in dialysate. J Chromatogr B Biomed Sci Appl 1997; 695: 444–447
  • Cidecyan A V, Aleman T S, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Gen 2004; 13: 525–534

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.